Publikation
Impact of Hyponatremia after Renal Transplantation on Decline of Renal Function, Graft Loss and Patient Survival: A Prospective Cohort Study
Wissenschaftlicher Artikel/Review - 27.08.2021
Berchtold Lena, Arampatzis Spyridon, de Seigneux Sophie, Huynh-Do Uyen, Amico Patrizia, Golshayan Déla, Schnyder Aurelia, Bonani Marco, Dahdal Suzan, Devetzis Vasileios, Achermann Rita, Filzer Anja, On Behalf Of Swiss Transplant Cohort Study Collaborators
Bereiche
PubMed
DOI
Zitation
Art
Zeitschrift
Veröffentlichungsdatum
eISSN (Online)
Kurzbeschreibung/Zielsetzung
BACKGROUND
Hyponatremia is one of the most common electrolyte disorders observed in hospitalized and ambulatory patients. Hyponatremia is associated with increased falls, fractures, prolonged hospitalisation and mortality. The clinical importance of hyponatremia in the renal transplant field is not well established, so the aim of this study was to determine the relationships between hyponatremia and mortality as main outcome and renal function decline and graft loss as secondary outcome among a prospective cohort of renal transplant recipients.
METHODS
This prospective cohort study included 1315 patients between 1 May 2008 and 31 December 2014. Hyponatremia was defined as sodium concentration below 136 mmol/L at 6 months after transplantation. The main endpoint was mortality. A secondary composite endpoint was also defined as: rapid decline in renal function (≥5 mL/min/1.73 m drop of the eGFR/year), graft loss or mortality.
RESULTS
Mean sodium was 140 ± 3.08 mmol/L. 97 patients displayed hyponatremia with a mean of 132.9 ± 3.05 mmol/L. Hyponatremia at 6 months after transplantation was associated neither with mortality (HR: 1.02; = 0.97, 95% CI: 0.47-2.19), nor with the composite outcome defined as rapid decline in renal function, graft loss or mortality (logrank test = 0.9).
CONCLUSIONS
Hyponatremia 6 months after transplantation is not associated with mortality in kidney allograft patients.